Thermo Fisher Scientific Acquires PPD, Inc.

Thermo Fisher Scientific Acquires Brammer Bio for $1.7 Billion

March 25, 2019

Biotechnology

Thermo Fisher Scientific agreed to acquire Brammer Bio, a viral vector CDMO focused on gene and cell therapies, for approximately $1.7 billion in cash. The deal expands Thermo Fisher’s pharma services and viral vector manufacturing capabilities to support high-growth gene and cell therapy markets and brings a team of nearly 600 employees into its pharma services business.

Thermo Fisher Scientific Acquires Solventum's Purification & Filtration Business

September 2, 2025

Manufacturing

Thermo Fisher Scientific completed the acquisition of Solventum's Purification & Filtration business for approximately $4.0 billion in cash. The divested business—now Thermo Fisher's Filtration and Separation business—adds bioprocessing filtration, industrial filtration and membrane technologies to Thermo Fisher's Life Sciences Solutions portfolio and is expected to generate about $750 million in revenue in 2025.

Thermo Fisher Scientific Acquires Olink Holding AB

July 10, 2024

Biotechnology

Thermo Fisher Scientific completed the acquisition of Olink Holding AB (publ) via a public cash tender offer at USD 26.00 per share/ADS, buying the proteomics company from shareholders including Summa Equity. The acquisition strengthens Thermo Fisher’s proteomics and protein-analysis capabilities, adding Olink’s high‑multiplex protein detection technology to its life‑science tools portfolio.

NFI Corp. Acquires PPS Inc.

July 7, 2021

Manufacturing

NFI Corp., a New Bedford, Massachusetts-based producer of custom printed graphic solutions, has acquired PPS Inc., a printed-graphics and printed-electronics manufacturer headquartered in Olathe, Kansas. NFI will relocate PPS's manufacturing to its New Bedford facility while maintaining a sales and administrative office in Kansas; the acquisition is intended to expand NFI's capabilities and customer base in the U.S.

Entegris Acquires MPD Chemicals

July 15, 2019

Manufacturing

Entegris, Inc. acquired MPD Chemicals for approximately $165 million in cash to expand its specialty chemicals and engineered materials portfolio. The acquisition enhances Entegris' capabilities in organosilane and organometallic deposition materials critical to semiconductor processing and advanced microelectronics applications.

Thermo Fisher Scientific Acquires The Binding Site Group

October 31, 2022

Medical Devices

Thermo Fisher Scientific has entered into a definitive agreement to acquire The Binding Site Group from a shareholder group led by Nordic Capital for £2.25 billion (about $2.6 billion). The Binding Site, a Birmingham-based specialist in protein and blood-cancer diagnostics with more than 1,100 employees and ~10% annual revenue growth, will join Thermo Fisher's Specialty Diagnostics segment to expand its capabilities in cancer diagnostics and monitoring.